Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Environ Sci Pollut Res Int ; 22(10): 7450-60, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25779108

RESUMO

Four light-duty vehicles (two diesel, one flex-fuel, and one gasoline vehicle) were tested as part of an intercomparison exercise of the world-harmonized light-duty vehicle test procedure (WLTP) aiming at measuring real-time ammonia emissions from the vehicles' raw exhaust at the tailpipe. The tests were conducted in the Vehicle Emission Laboratory (VELA) at the European Commission Joint Research Centre (EC-JRC), Ispra, Italy. HORIBA, CGS, and the Sustainable Transport Unit of the Joint Research Centre (JRC) took part in the measurement and analysis of the four vehicles' exhaust emissions over the world-harmonized light-duty vehicle test cycle class 3, version 5.3 using a HORIBA MEXA 1400 QL-NX, a CGS BLAQ-Sys, and the JRC Fourier transform infrared spectrometer, respectively. The measured ammonia concentrations and the emission profiles revealed that these three instruments are suitable to measure ammonia from the vehicles' raw exhaust, presenting no significant differences. Furthermore, results showed that measurement of ammonia from the vehicle exhaust using online systems can be performed guaranteeing the reproducibility and repeatability of the results. While no ammonia was detected for any of the two diesel vehicles (even though, one was equipped with a selective catalytic reduction system), we report average ammonia emission factors 8-10 mg/km (average concentrations 20-23 ppm) and 10-12 mg/km (average concentrations 22-24 ppm) for the flex-fuel and gasoline vehicles, respectively.


Assuntos
Amônia/análise , Emissões de Veículos/análise , Gasolina/análise , Itália , Reprodutibilidade dos Testes
2.
Gan To Kagaku Ryoho ; 30(6): 845-8, 2003 Jun.
Artigo em Japonês | MEDLINE | ID: mdl-12852354

RESUMO

The patient was a 71-year-old man with pleural effusion secondary to adenocarcinoma of the lung. Systemic chemotherapy with gemcitabine (GEM) and vinorelbine (VNR) was administered. This treatment brought a decrease in pleural effusion. After three cycles of the regimen with GEM and VNR, the regimen was changed to weekly paclitaxel. However, the paclitaxel regimen was not effective. Therefore, we returned to the former regimen. However, the pleural effusion was refractory to that regimen, and increased. We then added 5-FU to the regimen. This addition again brought a decrease in the pleural effusion, suggesting that the additional administration of UFT is effective against refractory malignant pleural effusion after the treatment regimen with GEM and VNR.


Assuntos
Adenocarcinoma/tratamento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Desoxicitidina/análogos & derivados , Resistencia a Medicamentos Antineoplásicos , Neoplasias Pulmonares/tratamento farmacológico , Derrame Pleural Maligno/tratamento farmacológico , Tegafur/administração & dosagem , Uracila/administração & dosagem , Vimblastina/análogos & derivados , Idoso , Desoxicitidina/administração & dosagem , Esquema de Medicação , Combinação de Medicamentos , Humanos , Masculino , Vimblastina/administração & dosagem , Vinorelbina , Gencitabina
3.
Gan To Kagaku Ryoho ; 30(4): 515-7, 2003 Apr.
Artigo em Japonês | MEDLINE | ID: mdl-12722684

RESUMO

A 74-year-old man with non-small cell lung cancer was referred to our hospital for chemotherapy. On admission, he suffered from high fever and left upper back pain. Laboratory data showed marked leukocytosis and increased CRP. He was treated with chemotherapy of weekly vinorelbine and gemcitabine. After the second cycle, the levels of leukocytes and CRP were remarkably decreased, and the severe back pain was also alleviated. He has been given an additional 4 cycles as an outpatient. He is now doing well. This regimen seems to be effective in alleviating symptoms and improving QOL.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Desoxicitidina/análogos & derivados , Neoplasias Pulmonares/tratamento farmacológico , Vimblastina/análogos & derivados , Idoso , Dor nas Costas/tratamento farmacológico , Carcinoma Pulmonar de Células não Pequenas/fisiopatologia , Desoxicitidina/administração & dosagem , Esquema de Medicação , Humanos , Neoplasias Pulmonares/fisiopatologia , Masculino , Qualidade de Vida , Vimblastina/administração & dosagem , Vinorelbina , Gencitabina
4.
J Chromatogr A ; 986(1): 83-8, 2003 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-12585325

RESUMO

We investigated hydrophobicity gradient columns composed of two columns packed with supports of different hydrophobicities in order to save time in protein separation by hydrophobic interaction chromatography at low salt concentration using a crude sample of trypsin inhibitor as a model sample. One of the two hydrophobicity gradient columns was packed with a support whose hydrophobicity was critically controlled for target protein (trypsin inhibitor) and the other was packed with a support which was less hydrophobic than the critically controlled hydrophobicity support. It was found that the hydrophobicity gradient columns are useful to separate samples containing impurities of a wide range of hydrophobicities within a reasonable time.


Assuntos
Cromatografia Líquida/métodos , Inibidores da Tripsina/isolamento & purificação , Concentração Osmolar , Sais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...